SAB Biotherapeutics Balance Sheet Health
Financial Health criteria checks 5/6
SAB Biotherapeutics has a total shareholder equity of $57.3M and total debt of $1.1M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are $83.9M and $26.6M respectively.
Key information
1.8%
Debt to equity ratio
US$1.05m
Debt
| Interest coverage ratio | n/a |
| Cash | US$56.57m |
| Equity | US$57.30m |
| Total liabilities | US$26.64m |
| Total assets | US$83.94m |
Recent financial health updates
Recent updates
Improved Revenues Required Before SAB Biotherapeutics, Inc. (NASDAQ:SABS) Stock's 42% Jump Looks Justified
Apr 17
Analysts Are Betting On SAB Biotherapeutics, Inc. (NASDAQ:SABS) With A Big Upgrade This Week
Jan 20Need To Know: Analysts Are Much More Bullish On SAB Biotherapeutics, Inc. (NASDAQ:SABS) Revenues
Nov 19Earnings Beat: SAB Biotherapeutics, Inc. (NASDAQ:SABS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Nov 18SAB Bio rises as H1N1 influenza and COVID-19 treatments show efficacy in trial
Sep 28What Does The Future Hold For SAB Biotherapeutics, Inc. (NASDAQ:SABS)? These Analysts Have Been Cutting Their Estimates
Aug 12SAB Biotherapeutics GAAP EPS of -$0.11 beats by $0.03
Aug 10Downgrade: Here's How Analysts See SAB Biotherapeutics, Inc. (NASDAQ:SABS) Performing In The Near Term
Apr 06SAB Biotherapeutics: Advancing A New Class Of Immunotherapies Leveraging Polyclonal Antibodies
Dec 02Financial Position Analysis
Short Term Liabilities: SABS's short term assets ($58.9M) exceed its short term liabilities ($10.8M).
Long Term Liabilities: SABS's short term assets ($58.9M) exceed its long term liabilities ($15.8M).
Debt to Equity History and Analysis
Debt Level: SABS has more cash than its total debt.
Reducing Debt: Insufficient data to determine if SABS's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SABS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SABS has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 39% each year.